Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$0.35.

  • Envoy Medical's EPS (Basic) rose 1025.64% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.36, marking a year-over-year decrease of 1623.93%. This contributed to the annual value of -$1.49 for FY2024, which is 4146.46% up from last year.
  • As of Q3 2025, Envoy Medical's EPS (Basic) stood at -$0.35, which was up 1025.64% from -$0.32 recorded in Q2 2025.
  • Over the past 5 years, Envoy Medical's EPS (Basic) peaked at $0.23 during Q1 2022, and registered a low of -$1.31 during Q2 2023.
  • Its 4-year average for EPS (Basic) is -$0.37, with a median of -$0.35 in 2025.
  • Over the last 5 years, Envoy Medical's EPS (Basic) had its largest YoY gain of 20000.0% in 2023, and its largest YoY loss of 228333.33% in 2023.
  • Envoy Medical's EPS (Basic) (Quarter) stood at -$1.13 in 2022, then surged by 55.0% to -$0.51 in 2023, then grew by 19.54% to -$0.41 in 2024, then rose by 14.73% to -$0.35 in 2025.
  • Its EPS (Basic) stands at -$0.35 for Q3 2025, versus -$0.32 for Q2 2025 and -$0.29 for Q1 2025.